Shares of Hamilton Thorne Ltd. (CVE:HTL – Get Free Report) traded up 4.3% during mid-day trading on Tuesday. The company traded as high as C$1.45 and last traded at C$1.45. 25,700 shares were traded during trading, a decline of 27% from the average session volume of 35,118 shares. The stock had previously closed at C$1.39.
Hamilton Thorne Stock Performance
The firm has a fifty day moving average price of C$1.45 and a 200 day moving average price of C$1.45. The company has a debt-to-equity ratio of 43.24, a quick ratio of 2.25 and a current ratio of 2.04. The stock has a market cap of C$149.69 million, a PE ratio of 58.94 and a beta of 0.54.
About Hamilton Thorne
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.
Further Reading
- Five stocks we like better than Hamilton Thorne
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?
Receive News & Ratings for Hamilton Thorne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne and related companies with MarketBeat.com's FREE daily email newsletter.
